Select Publications

* indicates co-first authors; ** indicates corresponding author(s)

Liu W*, Li J*, Tang Y, Zhao Y, Liu C, Song M, Ju Z, Kumar SV, Lu Y, Akbani R, Mills GB, Liang H** (2025)
DrBioRight 2.0: an LLM-powered bioinformatics chatbot for large-scale cancer functional proteomics analysis
Nature Communications 16(1):2256

Li J, Liu W, Mojumdar K, Kim H, Zhou Z, Ju Z, Kumar SV, Ng P, Chen H, Davies MA, Lu Y, Akbani R**, Mills GB**, Liang H** (2024)
A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies
Nature Cancer 5(10):1579-1595

Luo Y*, Xia Y*, Liu D*, Li X*, Li H*, Liu J*, Zhou D*, Dong Y*, Li X, Qian Y, Xu C, Tao K, Li G, Pan W, Zhong Q, Liu X, Xu S, Wang Z, Liu R, Zhang W, Shan W, Fang T, Wang S, Peng Z, Jin P, Jin N, Shi S, Chen Y, Wang M, Jiao X, Luo M, Gong W, Wang Y, Yao Y, Zhao Y, Huang X, Ji X, He Z, Zhao G, Liu R, Wu M, Chen G, Hong L, the COCPO Consortium, Ma D**, Fang Y**, Liang H** , Gao Q** (2024)
Neoadjuvant PARPi or Chemotherapy in Ovarian Cancer Informs Targeting Effector Treg Cells for Homologous-Recombination-Deficient Tumors
Cell 187(18):4905-4925

Zhou Z*, Chen MM*, Luo Y*, Mojumdar K, Peng X, Chen H, Kumar S, Akbani R, Lu Y, Liang H** (2022)
Tumor-intrinsic SIRPA Promotes Sensitivity to Checkpoint Inhibition Immunotherapy in Melanoma
Cancer Cell 40(11):1324-1340

Li J*, Chen H*, Wang Y*, Chen MM*, Liang H** (2021)
Next-generation analytics for omics data
Cancer Cell 39(1): 3-6

Zhao W*, Li J*, Chen MM, Luo Y, Ju Z, Nesser NK, Johnson-Camacho K, Boniface CT, Lawrence Y, Pande NY, Spellman PT, Davies MA, Herlyn M, Gray JW, von Euw E, Slamon DJ, Schultz A, Kumar SV, Korkut A, Akbani R, Lu Y, Brugge JS, Mills GB**, Liang H** (2020)
Large-scale characterization of drug responses of clinically relevant proteins in cancer cell lines
Cancer Cell 38(6): 829-843

Chen H, Liang H** (2020)
A high-resolution map of human enhancer RNA loci characterizes super-enhancer activities in cancer
Cancer Cell 38(5): 701-715

Yuan Y*, Ju YS*, Kim Y*, Li J, Wang Y, Yoon CJ, Yang Y, Martincorena I, Creighton CJ, Weinstein JN, Xu Y, Han L, Kim H-L, Nakagawa H, Park K**, Campbell PJ**, Liang H**; PCAWG Consortium (2020)
Comprehensive Molecular Characterization of Mitochondrial Genomes in Human Cancers
Nature Genetics 52 (3): 342-352

Chen H*, Li C*, Peng X, Zhou Z, Weinstein JN, The Cancer Genome Atlas Research Network, Liang H** (2018)
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples
Cell 173(2):386-399

Li J*, Zhao W*, Akbani R, Liu W, Ju Z, Ling S, Vellano CP, Roebuck P, Yu Q, Eterovic AK, Byers LA, Davies MA, Deng W, Vashisht Gopal YN, Chen G, von Euw EM, Slamon D, Conklin D, Heymach JV, Minna JD, Myers JN, Lu Y, Mills GB**, Liang H** (2017)
Characterization of human cancer cell lines by reverse phase protein arrays
Cancer Cell 31(2): 225-239

Yuan Y*, Liu L*, Chen H, Wang Y, Xu Y, Mao H, Li J, Mills GB, Shu Y, Li L, Liang H** (2016)
Comprehensive characterization of molecular differences in cancer between male and female patients
Cancer Cell 29(5): 711-722

Han L*, Diao L*, Yu S*, Xu X*, Li J, Zhang R, Yang Y , Werner HM, Eterovic KA, Yuan Y, Li J, Nair N, Minelli R, Tsang Y, Cheung LW, Jeong KJ, Roszik J, Ju Z, Woodman S, Lu Y, Scott KL, Li JB, Mills GB**, Liang H** (2015)
The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers
Cancer Cell 28(5):515-528

Yuan Y*, Van Allen EM*, Omberg L*, Wagle N, Amin-Mansour A, Sokolov A, Byers LA, Xu Y, Hess KR, Diao L, Han L, Huang X, Lawrence MS, Weinstein JN, Stuart JM, Mills GB, Garraway LA, Margolin AA**, Getz G**, Liang H** (2014)
Assessing the clinical utility of cancer genomic and proteomic data across tumor types
Nature Biotechnology 32 (7): 644-52

Li J*, Lu Y*, Akbani R, Ju Z, Roebuck PL, Liu W, Yang JY, Broom BM, Verhaak RG, Kane DW, Wakefield C, Weinstein JN, Mills GB**, Liang H** (2013)
TCPA: a resource for cancer functional proteomics data
Nature Methods 10 (11): 1046-1047